Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosurveillance

    Detecting Infection Before Symptoms Occur by Monitoring the Vagus Nerve

    By Stephanie LizotteAugust 1, 2019
    Antibodies and human brain with visible nervous system
    Credit: Global Biodefense
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research Projects Agency (BARDA) has partnered with the University of California San Diego to development a low-profile wearable for monitoring vagus nerve signal changes as a method of potentially enabling pre-symptomatic detection of infection.

    Dr. Imanuel Lerman will lead a team at UC San Diego, with the support of Qualcomm Institute, to continue fabrication and miniaturization activities of the Vagus Sentinel – Magnetometer (VS-M) system, creating a form factor device suitable for everyday use.

    VS-M will be developed to detect pathogen-specific, localized infections before symptoms emerge, thus improving situational awareness and potentially preventing a pandemic.

    Eventually such a technology could provide real-time information to public health and emergency responders of pathogen spread and allow them to provide timely prophylactic and preventative treatment, thus improving situational awareness and quenching the pandemic curve.

    The effort is part of BARDA’s Division of Research, Innovation, and Ventures (DRIVe) Early Notification to Act Control and Treat (ENACT) portfolio program, which supports the development of innovative products and approaches that aim to solve major health security challenges. Under this public-private partnership, DRIVe is contributing $557,340 of the total $796,200 project cost. UC San Diego will provide the remaining development costs for the In-Vivo Vagus Sentinels to Detect and Prevent Infection project.

    ASPR BARDA Editor Pick HHS Pandemic
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine
    Next Article Silverlon Wound Dressings Cleared by FDA for Injuries Caused by Mustard Gas

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.